For newly diagnosed BRAF mutated melanoma with brain metastases, do you prefer to start with targeted therapy or with immunotherapy?
Community PollStarted
What is the preferred systemic therapy option in BRAF mutated metastatic melanoma in the brain?
43 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · University of Texas MD Anderson Cancer Center
Answered on
Selection of systemic therapy, targeted therapy versus checkpoint immunotherapy, relies upon a comprehensive evaluation of patient's performance status, the number, size and location of brain metastases (BMs), neurological symptoms, and the extent of extracranial disease.
1. If the patient has poor ...
Join for free or sign in to see the full answer